We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MANUFACTURERS SAY FDA's GUIDANCE ON UNIFORMITY TOO BURDENSOME
The item has been added to your shopping cart.
MANUFACTURERS SAY FDA's GUIDANCE ON UNIFORMITY TOO BURDENSOME
March 26, 2004
Drug manufacturers have told the FDA that the number of samples recommended by the agency for testing in-process dosage units during tablet manufacturing is too high and would likely place a burden on firms.